Cargando…

The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer

Expression of estrogen and progesterone hormone receptors indicates a favorable prognosis due to the successful use of hormonal therapies such as tamoxifen and aromatase inhibitors. Unfortunately, 15–20% of patients will experience breast cancer recurrence despite continued use of tamoxifen. Drug re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Privette Vinnedge, Lisa M., Ho, Shuk-Mei, Wikenheiser-Brokamp, Kathryn A., Wells, Susanne I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468546/ https://www.ncbi.nlm.nih.gov/pubmed/23071688 http://dx.doi.org/10.1371/journal.pone.0046985

Ejemplares similares

The human DEK oncogene stimulates beta catenin signaling, invasion and mammosphere formation in breast cancer
por: Privette Vinnedge, Lisa M., et al.
Publicado: (2011)

The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor positive breast cancers
por: Privette Vinnedge, Lisa M., et al.
Publicado: (2014)

Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer
por: Pease, Nicholas A., et al.
Publicado: (2015)

Novel molecular mechanisms in Alzheimer’s disease: The potential role of DEK in disease pathogenesis
por: Greene, Allie N., et al.
Publicado: (2022)

DEK Expression in Breast Cancer Cells Leads to the Alternative Activation of Tumor Associated Macrophages
por: Pease, Nicholas A., et al.
Publicado: (2020)

Loss of DEK Expression Induces Alzheimer’s Disease Phenotypes in Differentiated SH-SY5Y Cells
por: Greene, Allie N., et al.
Publicado: (2020)

Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence
por: Matrka, Marie C., et al.
Publicado: (2018)

DEK is required for homologous recombination repair of DNA breaks
por: Smith, Eric A., et al.
Publicado: (2017)

PB2164: PROGNOSTIC IMPACT OF ONCOGENE DEK IN DIFFUSE LARGE B-CELL LYMPHOMA
por: Alonso Alonso, R., et al.
Publicado: (2022)

The human DEK oncogene regulates DNA damage response signaling and repair
por: Kavanaugh, Gina M., et al.
Publicado: (2011)

DEK promotes HPV positive and negative head and neck cancer cell proliferation
por: Adams, Allie K., et al.
Publicado: (2014)

Decreased plasma DEK Oncogene Levels Correlate with p16-Negative Disease and Advanced Tumor Stage in a Case–Control Study of Patients with Head and Neck Squamous Cell Carcinoma
por: Wise-Draper, Trisha, et al.
Publicado: (2017)

Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis
por: Matrka, Marie C., et al.
Publicado: (2017)

Role of the DEK oncogene in the development of squamous cell carcinoma
por: Ishida, Kazuhisa, et al.
Publicado: (2020)

Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers
por: Singh, Navneet, et al.
Publicado: (2022)

Potential of DEK proto-oncogene as a prognostic biomarker for colorectal cancer: An evidence-based review
por: Habiburrahman, Muhammad, et al.
Publicado: (2022)

Oncogene DEK is highly expressed in lung cancerous tissues and positively regulates cell proliferation as well as invasion
por: Zhou, Qian-Cheng, et al.
Publicado: (2018)

Promotion of cell proliferation by the proto‐oncogene DEK enhances oral squamous cell carcinogenesis through field cancerization
por: Nakashima, Takayuki, et al.
Publicado: (2017)

Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells
por: DONG, ZHONGYUN, et al.
Publicado: (2014)

DEK is highly expressed in breast cancer and is associated with malignant phenotype and progression
por: Yang, Mai-Qing, et al.
Publicado: (2021)

Defective transcription elongation in human cancers imposes targetable proteotoxic vulnerability
por: Muhammad, B., et al.
Publicado: (2021)

p53 suppresses carcinoma progression by inhibiting mTOR pathway activation
por: Akeno, Nagako, et al.
Publicado: (2014)

Steroid Hormone Receptor Signals as Prognosticators for Urothelial Tumor
por: Ide, Hiroki, et al.
Publicado: (2015)

The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners
por: Zhang, Yanan, et al.
Publicado: (2016)

DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma
por: Smith, Eric A., et al.
Publicado: (2017)

The SAF-box domain of chromatin protein DEK
por: Böhm, Friederike, et al.
Publicado: (2005)

A DEK domain-containing protein GhDEK2D mediated Gossypium hirsutum enhanced resistance to Verticillium dahliae
por: Zhou, Jinglong, et al.
Publicado: (2022)

Pulmonary alveolar microlithiasis
por: Kosciuk, Patrick, et al.
Publicado: (2020)

G-protein-coupled receptor controls steroid hormone signaling in cell membrane
por: Wang, Di, et al.
Publicado: (2015)

NMR-based metabolomic analysis identifies RON-DEK-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival
por: Vicente-Muñoz, Sara, et al.
Publicado: (2022)

Editorial: Steroid hormone receptors and cell cycle in breast cancer
por: Fabris, Victoria T., et al.
Publicado: (2023)

Sirtuins transduce STACs signals through steroid hormone receptors
por: Bayele, Henry K.
Publicado: (2020)

Doxorubicin induces prolonged DNA damage signal in cells overexpressing DEK isoform-2
por: Özçelik, Emrah, et al.
Publicado: (2022)

The role of DEK protein in hepatocellular carcinoma for progression and prognosis
por: Lin, Li-juan, et al.
Publicado: (2013)

The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival()
por: Hacker, Kari E, et al.
Publicado: (2018)

DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
por: Mor-Vaknin, Nirit, et al.
Publicado: (2017)

FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors – implications for therapy of luminal breast cancer
por: Piasecka, Dominika, et al.
Publicado: (2019)

IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival
por: Adams, Allie K., et al.
Publicado: (2015)

A conserved mechanism of sirtuin signalling through steroid hormone receptors
por: Bayele, Henry K.
Publicado: (2019)

The prognostic role of steroid hormone receptor signaling pathways in urothelial carcinoma
por: Nagata, Yujiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kh24to9u8a1jq8h0jg0blekb3c